Evaluation of the Safety and Efficacy of a Multienzyme Complex in Patients with Functional Dyspepsia: A Randomized, Double-Blind, Placebo-Controlled Study

Journal of Medicinal Food
Muhammed MajeedFurqan Ali

Abstract

Functional dyspepsia (FD) is a highly prevalent disorder having nonspecific symptoms and varied pathophysiology. Its treatment remains a challenge as therapeutic options are limited, unsatisfactory, and elusive. Thus, safety and efficacy of DigeZyme®, a proprietary multienzyme complex (MEC), was evaluated as a dietary supplement in FD patients. In this randomized, double-blind, placebo-controlled, parallel-group study, 40 patients were randomly assigned (1:1 ratio) to receive either MEC (50 mg, TID; n = 20) or placebo (n = 20) for 60 days. Reports of adverse or serious adverse events (AEs), abnormal results of vital signs, abnormal findings during physical examination, and abnormal laboratory investigations were monitored closely. Efficacy measures were change in Short-Form Leeds Dyspepsia Questionnaire (SF-LDQ), Nepean Dyspepsia Index-Short Form (NDI-SF), Visual Analog Scale (VAS), Clinical Global Impression Severity Rating Scale (CGI-S), and Glasgow Dyspepsia Severity Score (GDSS) at baseline and follow-up visits on day 15, 30, and 60. Supplementation with MEC was associated with statistically significant differences (P value ranging from .0401 to .0033) in all efficacy parameters compared with placebo. The between-group comp...Continue Reading

References

Oct 1, 1996·European Journal of Gastroenterology & Hepatology·E M el-OmarK E McColl
Aug 1, 1997·Scandinavian Journal of Gastroenterology·P G FarupK Ulshagen
Nov 19, 1997·Digestive Diseases and Sciences·B PfaffenbachM Wegener
Jan 9, 1999·Alimentary Pharmacology & Therapeutics·P MoayyediA T Axon
Sep 18, 1999·Digestive Diseases and Sciences·F SuarezJ S Barkin
Dec 23, 2003·The American Journal of Gastroenterology·Christine Feinle-BissetNicholas J Talley
May 18, 2004·The American Journal of Medicine·David A PeuraNicholas J Talley
Aug 25, 2004·Best Practice & Research. Clinical Gastroenterology·Filippo CremoniniNicholas J Talley
Nov 16, 2005·Gastroenterology·Nicholas J TalleyPaul Moayyedi
Feb 24, 2006·The New England Journal of Medicine·Gerald HoltmannChristopher Parow
May 24, 2006·World Journal of Gastroenterology : WJG·Andrew Seng Boon Chua
May 24, 2006·World Journal of Gastroenterology : WJG·Sanjiv Mahadeva, Khean-Lee Goh
Jul 5, 2006·The American Journal of Gastroenterology·Sander Veldhuyzen van ZantenAlly Gasco
Feb 3, 2007·Alimentary Pharmacology & Therapeutics·A FraserP Moayyedi
Feb 22, 2008·The American Journal of Gastroenterology·Nimish Vakil
Feb 11, 2009·Medical Principles and Practice : International Journal of the Kuwait University, Health Science Centre·Rieko OkadaNobuyuki Hamajima
Feb 6, 2010·Drugs of Today·Brian E LacyMichael D Crowell
Apr 23, 2010·Expert Opinion on Investigational Drugs·Noriaki ManabeMichael Camilleri
May 18, 2012·Alimentary Pharmacology & Therapeutics·B E LacyC Prather
Mar 7, 2013·Nature Reviews. Gastroenterology & Hepatology·Isobel Leake
Aug 21, 2013·Journal of Digestive Diseases·Sheng Liang Chen
Nov 5, 2015·The New England Journal of Medicine·Nicholas J Talley, Alexander C Ford
Jan 26, 2016·Current Drug Metabolism·Gianluca IaniroGiovanni Cammarota
Apr 7, 2016·The Korean Journal of Internal Medicine·Nicholas J Talley

❮ Previous
Next ❯

Citations

Feb 23, 2020·The American Journal of Gastroenterology·Jill K DeutschDavid J Hass

❮ Previous
Next ❯

Methods Mentioned

BETA
pregnancy test

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.